Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company announced the completion of enrollment in the ...

A previous diagnosis of a mental health disorder may predict neuropsychiatric complications in children with systemic lupus ...

Spinal epidural hematoma is a rare but potentially devastating condition that can result in permanent neurologic deficits if not diagnosed promptly. This case report presents a 48-year-old female ...

Santersus AG Announces Advancement of NucleoCapture into Pivotal Clinical Development strengthened by Strategic Collaboration with Terumo Zurich, Switzerland, 1st Dec 2025 – Santersus AG today ...

Study findings debunk the theory that lupus nephritis is more severe with worse outcomes in men vs women. Men and women with lupus nephritis exhibit similar disease severity, therapeutic responses, ...

Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors had a lower risk for rheumatic disease ...

As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, ...

Objective The question of sustained remission in SLE has been highlighted recently following data published on the use of chimeric antigen receptor-T cell therapy in SLE. With the review, we wanted to ...

Boehringer Ingelheim Pharma GmbH & Co. KG has described cyclic GMP-AMP synthase (MB21D1; cGAS) inhibitors reported to be useful for the treatment of autoinflammatory interferonopathy, idiopathic ...

A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.

Self-care, structured exercise, and reliable medication adherence help stabilize systemic lupus erythematosus and reduce long ...

Treatment with Benlysta (belimumab) can help people with lupus avoid disease flared and reduce their need for glucocorticoids ...